NASDAQ:CCCC

C4 Therapeutics Stock Predictions

etoro logo Buy CCCC
*Your capital is at risk
$3.96
-0.380 (-8.76%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CCCC Prediction Chart

CCCC Predictions History

Latest community submissions for CCCC.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 22, 2026 $3.00 -3.92% $3.07 V 97.65% 1
Apr 22, 2026 $3.02 -3.13% $3.07 V 98.44% 1
Apr 22, 2026 $3.06 -1.96% $3.07 V 99.64% 5
Apr 22, 2026 $3.39 +8.65% $3.07 X 89.58% 0
Aug 11, 2025 $2.44 -2.52% $2.42 V 99.30% 4
Aug 11, 2025 $4.23 +63.95% $2.42 X 25.21% 0
Feb 19, 2025 Bullish $3.01 V 1
Feb 14, 2025 Bullish $3.18 X 0
Feb 22, 2024 $7.50 +3.46% $8.80 V 85.24% 1
Feb 22, 2024 $7.09 -2.17% $8.80 X 80.60% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CCCC with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT C4 THERAPEUTICS INC
C4 Therapeutics
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma an...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE